Overview

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

Status:
RECRUITING
Trial end date:
2031-04-01
Target enrollment:
Participant gender:
Summary
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents with Fabry Disease.
Phase:
PHASE2
Details
Lead Sponsor:
Chiesi Farmaceutici S.p.A.
Collaborator:
ICON plc